Novavax, Inc. (NVAX) - NASDAQ
Company Description
Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like... More
Sector: Healthcare
Industry: Biotechnology
Country: United States